Lanolin Pharma & Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 18 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.50 M
- Revenue Growth -17.80%
- Profit Growth -48.79%
- Ebitda -38.86%
- Net Worth 984.48%
- Total Assets -1.40%
About Lanolin Pharma & Chemicals
Lanolin Pharma & Chemicals Private Limited (LPCPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 February 2014 and has a history of 11 years. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Lanolin Pharma & Chemicals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹5.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Priti Dsouza and Henry Dsouza serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100MH2014PTC252848
- Company No.
252848
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Lanolin Pharma & Chemicals Private Limited offer?
Lanolin Pharma & Chemicals Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Body Care Products, Carboxylate Esters, Ethyl Acetate, Inorganic Acids, Sulphuric Acid, Aromatic Hydrocarbon Solvent, Toluene, Nitric Acid, Aroma Chemicals.
Who are the key members and board of directors at Lanolin Pharma & Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priti Dsouza  | Additional Director | 03-Dec-2015 | Current |
| Henry Dsouza | Director | 05-Feb-2014 | Current |
Financial Performance of Lanolin Pharma & Chemicals.
Lanolin Pharma & Chemicals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 17.8% decrease. The company also saw a substantial fall in profitability, with a 48.79% decrease in profit. The company's net worth Soared by an impressive increase of 984.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lanolin Pharma & Chemicals?
In 2022, Lanolin Pharma & Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹5.50 M
Charges Breakdown by Lending Institutions
- Others : 0.35 Cr
- Bank Of India : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Dec 2022 | Others | ₹3.50 M | Satisfied |
| 08 Jul 2014 | Bank Of India | ₹2.00 M | Satisfied |
How Many Employees Work at Lanolin Pharma & Chemicals?
Unlock and access historical data on people associated with Lanolin Pharma & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lanolin Pharma & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lanolin Pharma & Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
